Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) EPS (Weighted Average and Diluted): 2010-2017

Historic EPS (Weighted Average and Diluted) for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Jun 2017 value amounting to -$0.52.

  • EyePoint Pharmaceuticals' EPS (Weighted Average and Diluted) fell 11.76% to -$0.19 in Q2 2016 from the same period last year, while for Jun 2016 it was -$0.69, marking a year-over-year decrease of 463.16%. This contributed to the annual value of -$0.52 for FY2017, which is 23.53% up from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.52 for FY2017, which was up 23.53% from -$0.68 recorded in FY2016.
  • In the past 5 years, EyePoint Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of $0.21 in FY2015 and a low of -$0.68 during FY2016.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$0.33, with a median of -$0.52 in 2017.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 142.86% in 2015, then tumbled by 423.81% in 2016.
  • EyePoint Pharmaceuticals' EPS (Weighted Average and Diluted) (Yearly) stood at -$0.52 in 2013, then climbed by 5.77% to -$0.49 in 2014, then spiked by 142.86% to $0.21 in 2015, then tumbled by 423.81% to -$0.68 in 2016, then climbed by 23.53% to -$0.52 in 2017.